NCT02402283View on ClinicalTrials.gov

Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Healthy
Interventions
DRUG

Metronidazole benzoate oral granules

Single oral dose of 400 mg

DRUG

Flagyl 400 mg Tablets

Single oral dose of 400 mg

Trial Locations (1)

11196

International Pharmaceutical Resaerch Center (IPRC), Amman

All Listed Sponsors
lead

Verisfield UK Ltd. Greek Branch

INDUSTRY

NCT02402283 - Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate | Biotech Hunter | Biotech Hunter